ATE238051T1 - Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen - Google Patents

Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen

Info

Publication number
ATE238051T1
ATE238051T1 AT99926687T AT99926687T ATE238051T1 AT E238051 T1 ATE238051 T1 AT E238051T1 AT 99926687 T AT99926687 T AT 99926687T AT 99926687 T AT99926687 T AT 99926687T AT E238051 T1 ATE238051 T1 AT E238051T1
Authority
AT
Austria
Prior art keywords
vitamin
esters
vulvitis
topical treatment
mucous membrane
Prior art date
Application number
AT99926687T
Other languages
German (de)
English (en)
Inventor
Giorgio Panin
Eleonora Annunziata
Original Assignee
Bio Lo Ga Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11380415&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE238051(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bio Lo Ga Srl filed Critical Bio Lo Ga Srl
Application granted granted Critical
Publication of ATE238051T1 publication Critical patent/ATE238051T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Communicable Diseases (AREA)
  • Gynecology & Obstetrics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT99926687T 1998-07-10 1999-07-05 Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen ATE238051T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI001586A ITMI981586A1 (it) 1998-07-10 1998-07-10 Vitamina e e suoi esteri per l'uso nel trattamento topico di patologie delle mucose
PCT/IB1999/001238 WO2000002554A1 (en) 1998-07-10 1999-07-05 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies

Publications (1)

Publication Number Publication Date
ATE238051T1 true ATE238051T1 (de) 2003-05-15

Family

ID=11380415

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99926687T ATE238051T1 (de) 1998-07-10 1999-07-05 Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen

Country Status (22)

Country Link
EP (1) EP1094807B1 (https=)
JP (1) JP2002520281A (https=)
CN (1) CN1135975C (https=)
AT (1) ATE238051T1 (https=)
AU (1) AU762860B2 (https=)
BR (1) BR9911945A (https=)
CA (1) CA2336990A1 (https=)
CZ (1) CZ301019B6 (https=)
DE (1) DE69907193T2 (https=)
DK (1) DK1094807T3 (https=)
ES (1) ES2196813T3 (https=)
HU (1) HU228921B1 (https=)
IL (1) IL140759A0 (https=)
IT (1) ITMI981586A1 (https=)
NO (1) NO20006719L (https=)
NZ (1) NZ509129A (https=)
PL (1) PL345500A1 (https=)
PT (1) PT1094807E (https=)
RU (2) RU2221561C2 (https=)
SK (1) SK284464B6 (https=)
TR (2) TR200103710T2 (https=)
WO (1) WO2000002554A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077604A1 (en) 2001-12-19 2004-04-22 Lenard Lichtenberger Method and compositions employing formulations of lecithin oils and nsaids for protecting the gastrointestinal tract and providingenhanced therapeutic activity
FR2819186A1 (fr) * 2001-01-10 2002-07-12 L M D Cystine-voie orale-syndrome de l'oeil sec
FR2825088A1 (fr) * 2001-05-25 2002-11-29 Derma Dev Nouveaux esters de tocopherol, leurs procedes d'obtention et leurs utilisations
US7485666B2 (en) * 2004-06-17 2009-02-03 Kimberly-Clark Worldwide, Inc. Vaginal health products
US8541413B2 (en) * 2004-10-01 2013-09-24 Ramscor, Inc. Sustained release eye drop formulations
US9993558B2 (en) 2004-10-01 2018-06-12 Ramscor, Inc. Sustained release eye drop formulations
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
AU2006220248B2 (en) * 2005-03-03 2012-06-21 Vital Health Sciences Pty Ltd Compounds having lipid lowering properties
BRPI0920326A2 (pt) * 2008-10-09 2016-02-23 Ramscor Inc composição e método para tratamento da síndrome do olho ressecado
IT1394063B1 (it) * 2009-05-11 2012-05-25 Giuliani Spa Composizione per uso oftalmico adatta al trattamento degli stati infiammatori dell'occhio e della sindrome dell'occhio secco
US9192594B2 (en) * 2009-07-27 2015-11-24 Renato Sanseverino Ophthalmic solution for protecting internal structures of the eyeball against UV-A rays or for the treatment of keratoconus with a trans-epithelial cross-linking technique
CN103957888B (zh) 2011-09-29 2017-11-21 PLx 制药公司 用于将药物沿胃肠道靶向释放的pH依赖性载体、其组合物及其制备和应用
WO2013185024A1 (en) * 2012-06-08 2013-12-12 The Ohio State University Treating burn and scar injury using tocotrienol
DE202014106007U1 (de) * 2014-07-22 2015-07-23 Bio.Lo.Ga. S.R.L. Zusammensetzung zur Verwendung in der Vorbeugung und Behandlung allergischer Rhinitis
CN107438429A (zh) * 2014-10-22 2017-12-05 拜洛嘉有限责任公司 用于增加鼻粘膜的营养作用的药物组合物
JP2018507895A (ja) 2015-03-18 2018-03-22 バイオヌークス スイス エスエー ヘルペスを処置するための方法において使用するためのジヒドロケルセチンを含む組成物
JP2017119669A (ja) * 2015-10-15 2017-07-06 ロート製薬株式会社 異物感改善用眼科組成物
EP3849514A1 (en) * 2018-09-12 2021-07-21 Neilos S.r.l. A composition for use in the prevention and/or treatment of epistaxis
IT202000003620A1 (it) * 2020-02-21 2021-08-21 Hulka S R L Uso di una formulazione per applicazione topica per il mantenimento dell’omeostasi vaginale
AU2021244695A1 (en) 2020-03-26 2022-11-10 Plx Opco Inc. Pharmaceutical carriers capable of pH dependent reconstitution and methods for making and using same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216812A (ja) * 1983-05-26 1984-12-06 Dowa Yakushiyou Kk 頭髪育毛料
JP2776837B2 (ja) * 1988-08-11 1998-07-16 日本レダリー株式会社 消化性潰瘍治療剤
US5032384A (en) * 1989-01-27 1991-07-16 Block Drug Company, Inc. Compositions and method for the treatment of disease
SU1628281A3 (ru) * 1989-03-30 1994-02-28 Научно-производственная фирма "Флори" Ранозаживляющее средство
IT1249711B (it) * 1991-09-30 1995-03-09 Boniscontro E Gazzone S R L Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici,indicate nella terapia dei tessuti superficiali.
JP2811036B2 (ja) * 1992-05-26 1998-10-15 参天製薬株式会社 ビタミンe点眼剤
JP3551977B2 (ja) * 1993-04-08 2004-08-11 ライオン株式会社 安定なビタミンa類及びビタミンe類可溶化点眼剤
CN1039087C (zh) * 1993-12-29 1998-07-15 昆明宏达实业有限总公司 妇科病治疗保健外用药物
RU2125887C1 (ru) * 1995-08-25 1999-02-10 Владивостокский государственный медицинский университет Способ приготовления липосомального интерферона
IT1282778B1 (it) * 1996-05-31 1998-03-31 Giorgio Panin Vitamina "e" acetato quale prodotto per applicazione topica
JPH10109934A (ja) * 1996-10-04 1998-04-28 Sekisui Chem Co Ltd 炎症性眼疾患用剤
JPH10231243A (ja) * 1997-02-20 1998-09-02 Sekisui Chem Co Ltd 粘膜炎症外用薬

Also Published As

Publication number Publication date
WO2000002554A1 (en) 2000-01-20
AU4385899A (en) 2000-02-01
CN1135975C (zh) 2004-01-28
CZ301019B6 (cs) 2009-10-14
DE69907193D1 (de) 2003-05-28
CZ200136A3 (cs) 2001-08-15
HU228921B1 (en) 2013-06-28
CN1308531A (zh) 2001-08-15
NO20006719D0 (no) 2000-12-29
AU762860B2 (en) 2003-07-10
JP2002520281A (ja) 2002-07-09
TR200103710T2 (tr) 2002-06-21
TR200100014T2 (tr) 2001-06-21
RU2221561C2 (ru) 2004-01-20
NO20006719L (no) 2001-02-16
DE69907193T2 (de) 2004-04-08
ES2196813T3 (es) 2003-12-16
NZ509129A (en) 2003-10-31
SK352001A3 (en) 2001-06-11
EP1094807A1 (en) 2001-05-02
DK1094807T3 (da) 2003-08-11
IL140759A0 (en) 2002-02-10
PT1094807E (pt) 2003-08-29
PL345500A1 (en) 2001-12-17
HUP0102781A2 (hu) 2001-12-28
BR9911945A (pt) 2001-03-27
ITMI981586A1 (it) 2000-01-10
ITMI981586A0 (it) 1998-07-10
SK284464B6 (sk) 2005-04-01
EP1094807B1 (en) 2003-04-23
RU2003128023A (ru) 2005-04-10
CA2336990A1 (en) 2000-01-20
HUP0102781A3 (en) 2002-04-29

Similar Documents

Publication Publication Date Title
ATE238051T1 (de) Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen
CU23436B6 (es) Método para tratar inflamaciones del colon, recto, canal anal o región perianal
NO20044699L (no) Vaginalpleiesammensetning
ATE337785T1 (de) Tiotropiumsalze zur behandlung von entzündlichen erkrankungen
ATE237330T1 (de) Verabreichung von nikotin im dickdarm zur behandlung von entzündlicher eingeweidenerkrankung
AR035637A1 (es) Betamimeticos de larga accion, procedimiento para su preparacion y su empleo como medicamentos
ES2182915T3 (es) Procedimiento de purificacion del factor viii
MXPA03010435A (es) Derivados de oxazol acido carboxilico sustituidos para uso como activadores de proliferacion del peroximosa(ppar-alfa y gama) en el tratamiento de diabetes.
DK0738270T3 (da) Dihydropyrazolopyrroler
AR034619A1 (es) Formulaciones de olopatadine para administracion topica
EA200400881A1 (ru) Азаарилпиперазины
ATE470446T1 (de) Neues verfahren und zusammensetzungen zur örtlichen behandlung von meniere-krankheit, tinnitus und/oder hörverlust
NO20025510D0 (no) Tienodibenzoazulenforbindelser som tumor nekrose faktor inhibitorer
DK1128835T3 (da) Cyanocobalamin (vitamin 12)-behandling ved allergisk sygdom
ATE350011T1 (de) Pharmazeutische zusammensetzung zur behandlung von ulzerationen und/oder erosionen des schleimhautepithels
EA200801698A1 (ru) Лекарственные композиции для применения в вагине
ATE311191T1 (de) Apoptotische körper zur verwendung in der behandlung von t-zell-vermittelten- und entzündungserkrankungen
AU2003225131A1 (en) 3-substituted amino-1h-indole-2-carboxylic acid and 3-substituted amino-benzo' b! thiophene-2-carboxylic acid derivatives as interieukin-4 gene expression inhibitors
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
ATE345123T1 (de) Behandlung von angiogenesebezogenen krankheiten mit benzoyl phenylessigsäure derivaten
ATE330596T1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
ATE407686T1 (de) Medikament auf basis von honig, seine herstellung und verwendung
ATE535237T1 (de) Verwendung von fts zur behandlung von malignen erkrankungen
HUP9902417A2 (hu) Alfa-ketoészterek, és alfa-ketoamidok acilezett enol-származékai
NO20003931L (no) Hydroksam- og karboksylsyrederivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1094807

Country of ref document: EP